Rhinoorbital mucormycosis in the immunocompetent: Experience with Isavuconazole | Zendy

Marta Ilharco | Zendy; Carla Maravilha Pereira | Zendy; Laura Magalhães Moreira | Zendy; Ana Luísa Proença | Zendy; Maria do Carmo Fevereiro | Zendy; Fátima Lampreia | Zendy; Miguel Lopes Oliveira | Zendy; José Rola | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Rhinoorbital mucormycosis in the immunocompetent: Experience with Isavuconazole

Author(s) -

Marta Ilharco,

Carla Maravilha Pereira,

Laura Magalhães Moreira,

Ana Luísa Proença,

Maria do Carmo Fevereiro,

Fátima Lampreia,

Miguel Lopes Oliveira,

José Rola

Publication year - 2019

Publication title -

idcases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.319

H-Index - 13

ISSN - 2214-2509

DOI - 10.1016/j.idcr.2019.e00591

Subject(s) - medicine , posaconazole , mucormycosis , immunosuppression , antifungal , surgery , debridement (dental) , mucorales , incidence (geometry) , amphotericin b , surgical debridement , dermatology , physics , optics

Highlights • Mucormycosis is an opportunistic fungal infection caused by fungi of the order Mucorales.• Early diagnosis of mucormycosis is key to the improvement of patients’ survival.• LAmB is the treatment of choice, combined with aggressive surgical debridement.• Posaconazole, Isavuconazole and hyperbaric oxygen are examples of available salvage therapies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research